CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castanelli, D. J.
Right arrow Articles by Clavel, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castanelli, D. J.
Right arrow Articles by Clavel, N. A.
Canadian Journal of Anesthesia 52:1064-1070 (2005)
© Canadian Anesthesiologists' Society, 2005

Obstetrical and Pediatric Anesthesia

Remifentanil decreases sevoflurane requirements in children

[Le rémifentanil diminue les besoins de sévoflurane chez les enfants]

Damian J. Castanelli, MBBS Fanza*, William M. Splinter, MD FRCPC{dagger} and Natalie A. Clavel, BSc{dagger}

* From the Department of Anaesthesia, Monash Medical Centre, Clayton, Victoria, Australia; and
{dagger} the Department of Anesthesiology, The Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada.

Address correspondence to: Dr. William Splinter, Chief, Department of Anesthesiology, Children’s Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada. E-mail: splinter{at}cheo.on.ca

Purpose: To establish the effect of increasing concentrations of remifentanil on sevoflurane requirements in children.

Methods: Fifty-eight healthy patients, ASA status I–II aged two to 12 yr, undergoing abdominal wall hernia or hydrocele repairs were serially assigned to one of four test groups to receive remifentanil 0.03 µg·kg–1·min–1, 0.06 µg·kg–1·min–1, 0.12 µg·kg–1·min–1, or 0.25 µg·kg–1·min–1 iv. Patients received a bolus of remifentanil 1 µg·kg–1 iv before the infusion began. End-tidal sevoflurane concentration was adjusted according to a Dixon up-and-down approach. Ten minutes after starting the remifentanil infusion, the surgical incision was made. The patient was observed for one minute from the time of incision by a solitary blinded rater for either flexion or withdrawal of one or more extremities in response to skin incision.

Results: The mean minimum alveolar concentration of sevoflurane was 2.39 ± 0.58 with 0.03 µg·kg–1·min–1 remifentanil, 1.91 ± 0.36 with 0.06 µg·kg–1·min–1 remifentanil, and 0.92 ± 0.11 with 0.12 µg·kg–1·min–1 remifentanil. Remifentanil 0.25 µg·kg–1·min–1 lead to the sevoflurane being decreased to a level associated with spontaneous patient awakening.

The effective dose (ED50) values of sevoflurane were 2.44 [95% confidence interval (CI) 2.16–2.72], 2.00 (95% CI 1.78–2.22), and 1.18 (95% CI 0.99–1.36) for remifentanil infusion rates of 0.03 µg·kg–1·min–1, 0.06 µg·kg–1·min–1, and 0.12 µg·kg–1·min–1 respectively.

Conclusion: The administration of remifentanil produced a dose-dependent decrease in the minimum alveolar concentration of sevoflurane necessary for inhibition of movement reaction in response to surgical incision. The use of remifentanil may allow for flexible analgesic control and rapid recovery in children anesthetized with sevoflurane.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Canadian Anesthesiologists' Society.